Skip to main content
. 2024 Mar 11;14:1361300. doi: 10.3389/fonc.2024.1361300

Table 3.

Characteristics of patients in the pCR and non-pCR groups after treatment.

pCR (n=15), n (%) Non-pCR (n=38), n (%)
ypTNM stage
 I NA 12 (31.6%)
 II NA 14 (36.8%)
 III NA 12 (31.6%)
ypT status
 T0 NA 0
 T1 NA 5 (13.1%)
 T2 NA 13 (34.2%)
 T3 NA 18 (47.4%)
 T4 NA 2 (5.3%)
ypN status
 N0 NA 26 (68.4%)
 N1 NA 10 (26.3%)
 N2 NA 2 (5.3%)